Prostate-specific antigen and prostate cancer: prediction, detection and monitoring

Hans Lilja, David Ulmert, Andrew J Vickers

Research output: Contribution to journalReview articlepeer-review

Abstract

Testing for prostate-specific antigen ( PSA) has profoundly affected the diagnosis and treatment of prostate cancer. PSA testing has enabled physicians to detect prostate tumours while they are still small, low-grade and localized. This very ability has, however, created controversy over whether we are now diagnosing and treating insignificant cancers. PSA testing has also transformed the monitoring of treatment response and detection of disease recurrence. Much current research is directed at establishing the most appropriate uses of PSA testing and at developing methods to improve on the conventional PSA test.
Original languageEnglish
Pages (from-to)268-278
JournalNature Reviews. Cancer
Volume8
Issue number4
DOIs
Publication statusPublished - 2008

Subject classification (UKÄ)

  • Medicinal Chemistry

Fingerprint

Dive into the research topics of 'Prostate-specific antigen and prostate cancer: prediction, detection and monitoring'. Together they form a unique fingerprint.

Cite this